INTERFERON BETA-1B for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 842 adverse event reports in the FDA FAERS database where INTERFERON BETA-1B was used for Product used for unknown indication.
Most Reported Side Effects for INTERFERON BETA-1B
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Multiple sclerosis relapse | 1,229 | 10.0% | 12 | 312 |
| Influenza like illness | 1,042 | 8.4% | 1 | 110 |
| Injection site pain | 1,014 | 8.2% | 3 | 122 |
| Fatigue | 783 | 6.3% | 9 | 130 |
| Drug ineffective | 767 | 6.2% | 7 | 53 |
| Injection site erythema | 724 | 5.9% | 1 | 73 |
| Injection site reaction | 707 | 5.7% | 0 | 86 |
| Pain | 597 | 4.8% | 6 | 115 |
| Headache | 596 | 4.8% | 6 | 134 |
| Multiple sclerosis | 589 | 4.8% | 24 | 116 |
| Gait disturbance | 525 | 4.3% | 7 | 157 |
| Death | 501 | 4.1% | 501 | 41 |
| Injection site bruising | 480 | 3.9% | 0 | 32 |
| Pyrexia | 475 | 3.9% | 10 | 135 |
| Chills | 460 | 3.7% | 3 | 69 |
Other Indications for INTERFERON BETA-1B
Multiple sclerosis (7,192)
Relapsing-remitting multiple sclerosis (694)
Secondary progressive multiple sclerosis (146)
Covid-19 (93)
Multiple sclerosis relapse (28)
Chronic myeloid leukaemia (26)
Clinically isolated syndrome (18)
Covid-19 pneumonia (16)
Relapsing multiple sclerosis (15)
Hepatitis c (13)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)